Sppi stock will rise drasticaly after getting a foothold in Canada
Created when NASDAQ:SPPI was $1.39 | Edit | History
I believe that the United Stated FDA and its lengthy approval time is hurting the smaller pharmaceutical companys,on the other hand,Canada with its universal health care has a network of test people for new drugs that bypass the FDA approval process and will allow quicker development of drugs thus saving valuable time and resorce monies,I believe that the stock price will be doubled in 2 months.